INTRODUCTION
number of patient with the diseases presenting to the hospital. It is therefore worrisome to note that in Nigeria and other African countries, despite reports on rising incidences of kidney diseases [2] [3] [4] [5] [6] , there seems to be steeply steady decline in kidney biopsies in the region. In order to quantify this assertion, we retrospectively investigated the trend of renal histopathology requests at Pathology Department, UCH, Ibadan.
MATERIALS AND METHODS
All the renal biopsies (including nephrectomies and trucut biopsies) submitted to the Department of Pathology of the UCH, Ibadan, South-West Nigeria and documented in the Surgical Day-Book over a 31-year period (January 1981 to December 2011) were analysed. Using trend test, we studied the trend of histopathology requests from the Medicine, Paediatrics and Surgical Departments. We also analysed the differences in trend by gender. (p<0.001) while the requests from Surgery Departments remained unchanged over this period (p=0.05). A significant decline across the ages in both genders (figures 2). Before 1993, an average of 10 to 20 renal biopsies was performed in a year, but the value dropped significantly plateauing to average of 1 to 10 per year for more than two and half decades.
DISCUSSION
Renal biopsy subjected to histopathological analysis is the only form of making a definitive diagnosis for patients with kidney parenchymal disease. There are diverse indications for renal biopsy which vary from centre to centre 7 . Disease activity, progression and prognostication are monitored with renal biopsies 8 . Analysis of renal biopsy data is needed for the study of prevalence of biopsy-proven renal disease (BPRD), distribution and variation with respect to gender, race, age, geographic locations, and socioeconomic status. It is also used to determine the usual indications for renal biopsy and for studying the regional epidemiology of glomerular disease in a particular geographical region. The understanding of the utility of renal biopsy which acts as a template for future research into renal parenchymal disease cannot be over emphasized. Unfortunately, this single most important diagnostic tool seems to be gradually going into extinction in Nigeria even in the face of rising incidence of renal parenchymal disease in Nigeria 9 . This index study shows that before 1993, an average of 15 to 20 renal biopsies per year were performed by both the Medicine and Paediatrics Departments of UCH, Ibadan. This value dropped sharply after 1993 to as low as one to ten biopsies per year in average till 2011. What could be the cause of this persistent drop in biopsy rate at the University College hospital (UCH) is a subject for further studies.
The UCH, Ibadan is strategically located in Ibadan. The Hospital started in 1948 but was legally backed by an act of parliament in November 1952. The University College Hospital, Ibadan was initially commissioned with 500 bed spaces in 1957 after the completion of the physical structures, currently the hospital has 850 bed spaces and 163 examination couches. The current rates of bed occupancy ranges from 55-60%. It is therefore, worrisome to believe that renal biopsies would keep declining instead of increasing 10 .
In Nigeria, there are documented evidences that suggest a consistent rise in incidence of kidney diseases. Various authors have speciûcally reported that chronic kidney disease (CKD) are on the increase in younger and old age groups 11 . Other countries in the world have also shown evidences of increase in CKD cases irrespective of the age groups and sexes. In the United States of America, the prevalence of End State Renal disease (ESRD) among blacks is high vis-à-vis other races. With this information, it may be inferred, owing to the facts that there are no reliable data in kidney disease burden in Africa, that there may be a high prevalence of ESRD in Africa as a whole. In Nigerian, adults with CKD, glomerulonephritis and hypertension were identified as the common causes, while glomerulonephritis and posterior urethral valves were seen as the common causes in children while diabetes and hypertension were common causes of CKD in the United States of America. It is however, expected that increase disease prevalence in a society will in a way lead to increase in number of patients seeking medical attention and by extrapolation increase in demand for laboratory investigations specific for the patient care optimization. Surprisingly, we found a steady decline in renal biopsy despite a consistent report on increase in renal diseases in Nigeria. This decline in request for biopsies may not be unconnected to the limitation in access to renal replacement therapy (RRT) in Nigeria and a high mortality rate being recorded among individuals with CKD. Currently, there is paucity of training and experience on treatment of patients in Nigeria. Renal transplantation which is adjudged the best form of RRT in terms of cost and quality of life has a less than 1% utilization in Nigeria 12 .
The University College Hospital Ibadan is one of the Hospitals where renal transplantation is done in Nigeria and it is surprising to note that renal biopsy rates were higher during the pre-renal transplantation era than this period when the hospital could afford the best form of RRT.
One key factor that influences limitation to total health care of CKD patients is the fact that patients pay for every form of medical care out-of-pocket, Arije et al reported 13 . Another factor negating the efficacy of health care delivery is the decline in number of trained and skilled personnel with clinical and diagnostic dexterity in managing renal patients. In those countries that have experienced reduction in CKD, the evidence appears to suggest that overall; they have adequately trained personnel, adequate funding and health policies that promote efficient healthcare delivery to the citizenry 14 .
CONCLUSION
There is need to perform further studies on the factors affecting the decline in renal biopsy requests in Nigeria. Lack of adequate man-power, facilities and political will may not be unconnected to the steady decline in renal biopsy even in the face of increase in renal diseases in Nigeria.
